Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Deferred Taxes (2019)

Tandem Diabetes Care (TNDM) has disclosed Deferred Taxes for 1 consecutive years, with -$25000.0 as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Deferred Taxes changed N/A year-over-year to -$25000.0, compared with a TTM value of -$25000.0 through Sep 2021, changed N/A, and an annual FY2020 reading of -$2.1 million, down 8404.0% over the prior year.
  • Deferred Taxes was -$25000.0 for Q4 2019 at Tandem Diabetes Care.
  • Across five years, Deferred Taxes topped out at -$25000.0 in Q4 2019 and bottomed at -$25000.0 in Q4 2019.